India and South Africa recently urged the World Trade Organization to suspend intellectual property protections for COVID-19 vaccines and treatments. The claim is that this would allow developing countries to manufacture “cheap” COVID-19 therapeutics and vaccines, hastening the end to the pandemic—at least, that’s what proponents claim. They’re wrong. Dangerously wrong. Gutting IP protections won’t make COVID-19 medications more readily available but it will set a terrible precedent that will chill future medical innovation.
Patent
- Enablement
- Fee Shifting
- Litigation
- Balancing Innovation and Competition: Thomas Jefferson’s View of Obviousness for Mechanical Inventions
- Design Patents: Under Utilized and Overlooked
- Deciding Where to Obtain International Patent Rights
- The New Copyright Small Claims Board Presents Problems for Copyright Owners and Small Businesses
- From Home Security to VoIP: Honoring Black Women Inventors of the Last Half-Century
Recent Posts
- Balancing Innovation and Competition: Thomas Jefferson’s View of Obviousness for Mechanical Inventions
- Design Patents: Under Utilized and Overlooked
- Deciding Where to Obtain International Patent Rights
- The New Copyright Small Claims Board Presents Problems for Copyright Owners and Small Businesses
- From Home Security to VoIP: Honoring Black Women Inventors of the Last Half-Century